Authors:
Thervet, E
Anglicheau, D
Toledano, N
Houllier, AM
Noel, LH
Kreis, H
Beaune, P
Legendre, C
Citation: E. Thervet et al., Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients, J AM S NEPH, 12(1), 2001, pp. 170-176
Authors:
Verstuyft, C
Morin, S
Robert, A
Loriot, MA
Beaune, P
Jaillon, P
Becquemont, L
Citation: C. Verstuyft et al., Early acenocoumarol overanticoagulation among cytochrome P4502C9 poor metabolizers, PHARMACOGEN, 11(8), 2001, pp. 735-737
Authors:
Loriot, MA
Rebuissou, S
Oscarson, M
Cenee, S
Miyamoto, M
Ariyoshi, N
Kamataki, T
Hemon, D
Beaune, P
Stucker, I
Citation: Ma. Loriot et al., Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population, PHARMACOGEN, 11(1), 2001, pp. 39-44
Authors:
Cauchi, S
Stucker, I
Solas, C
Laurent-Puig, P
Cenee, S
Hemon, D
Jacquet, M
Kremers, P
Beaune, P
Massaad-Massade, L
Citation: S. Cauchi et al., Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer, CARCINOGENE, 22(11), 2001, pp. 1819-1824
Authors:
Rosty, C
Chazal, M
Etienne, MC
Letoublon, C
Bourgeon, A
Delpero, JR
Pezet, D
Beaune, P
Laurent-Puig, P
Milano, G
Citation: C. Rosty et al., Determination of microsatellite instability, p53 and K-ras mutations in hepatic metastases from patients with colorectal cancer: Relationship with response to 5-fluorouracil and survival, INT J CANC, 95(3), 2001, pp. 162-167
Authors:
Cabelguenne, A
Loriot, MA
Stucker, I
Blons, H
Koum-Besson, E
Brasnu, D
Beaune, P
Laccourreye, O
Laurent-Puig, P
De Waziers, I
Citation: A. Cabelguenne et al., Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy, INT J CANC, 93(5), 2001, pp. 725-730
Authors:
Vernia, S
Beaune, P
Coloma, J
Lopez-Garcia, MP
Citation: S. Vernia et al., Differential sensitivity of rat hepatocyte CYP isoforms to self-generated nitric oxide, FEBS LETTER, 488(1-2), 2001, pp. 59-63
Citation: E. Boitier et P. Beaune, Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders - An update, CL R ALL IM, 18(2), 2000, pp. 215-239
Authors:
Wolkenstein, P
Loriot, MA
Aractingi, S
Cabelguenne, A
Beaune, P
Chosidow, O
Citation: P. Wolkenstein et al., Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS, PHARMACOGEN, 10(9), 2000, pp. 821-828
Authors:
Ariyoshi, N
Takahashi, Y
Miyamoto, M
Umetsu, Y
Daigo, S
Tateishi, T
Kobayashi, S
Mizorogi, Y
Loriot, MA
Stucker, I
Beaune, P
Kinoshita, M
Kamataki, T
Citation: N. Ariyoshi et al., Structural characterization of a new variant of the CYP2A6 gene (CYP2A61B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C, PHARMACOGEN, 10(8), 2000, pp. 687-693
Authors:
Stucker, I
Jacquet, M
de Waziers, I
Cenee, S
Beaune, P
Kremers, P
Hemon, D
Citation: I. Stucker et al., Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a Frenchpopulation, PHARMACOGEN, 10(7), 2000, pp. 617-627
Authors:
El Adlouni, C
Pinelli, E
Azemar, B
Zaoui, D
Beaune, P
Pfohl-Leszkowicz, A
Citation: C. El Adlouni et al., Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A:Role of CYP2C9 and microsomal glutathione-S-transferase, ENV MOL MUT, 35(2), 2000, pp. 123-131
Authors:
Cabelguenne, A
Blons, H
de Waziers, I
Carnot, F
Houllier, AM
Soussi, T
Brasnu, D
Beaune, P
Luccourreye, O
Laurent-Puig, P
Citation: A. Cabelguenne et al., p53 alterations predict tumor response to neoadjuvant chemotherapy in headand neck squamous cell carcinoma: A prospective series, J CL ONCOL, 18(7), 2000, pp. 1465-1473
Authors:
De Berardinis, V
Moulis, C
Maurice, M
Beaune, P
Pessayre, D
Pompon, D
Loeper, J
Citation: V. De Berardinis et al., Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes, MOLEC PHARM, 58(3), 2000, pp. 542-551
Authors:
Piipari, R
Savela, K
Nurminen, T
Hukkanen, J
Raunio, H
Hakkola, J
Mantyla, T
Beaune, P
Edwards, RJ
Boobis, AR
Anttila, S
Citation: R. Piipari et al., Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers, INT J CANC, 86(5), 2000, pp. 610-616
Authors:
Massaad-Massade, L
Massaad, C
Legendre, F
Bas, V
Chottard, JC
Beaune, P
Barouki, R
Citation: L. Massaad-massade et al., A single d(GpG) cisplatin adduct on the estrogen response element decreases the binding of the estrogen receptor, FEBS LETTER, 466(1), 2000, pp. 49-53
Authors:
Simon, T
Becquemont, L
Mary-Krause, M
de Waziers, I
Beaune, P
Funck-Brentano, C
Jaillon, P
Citation: T. Simon et al., Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity, CLIN PHARM, 67(4), 2000, pp. 432-437
Authors:
Coulet, F
Blons, H
Cabelguenne, A
Lecomte, T
Laccourreye, O
Brasnu, D
Beaune, P
Zucman, J
Laurent-Puig, P
Citation: F. Coulet et al., Detection plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis, CANCER RES, 60(3), 2000, pp. 707-711
Authors:
Blons, H
Radicella, JP
Laccourreye, O
Brasnu, D
Beaune, P
Boiteux, S
Laurent-Puig, P
Citation: H. Blons et al., Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer, MOL CARCINO, 26(4), 1999, pp. 254-260
Authors:
Nielsen, TL
Rasmussen, BB
Flinois, JP
Beaune, P
Brosen, K
Citation: Tl. Nielsen et al., In vitro metabolism of quinidine: The (3S)-3-hydroxylation of quinidine isa specific marker reaction for cytochrome P-4503A4 activity in human livermicrosomes, J PHARM EXP, 289(1), 1999, pp. 31-37